Jefferies Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-15,476
Closed -$556K 2247
2020
Q1
$556K Buy
+15,476
New +$880K 0.01% 1276
2019
Q4
Sell
-11,003
Closed -$823K 3200
2019
Q3
$823K Buy
+11,003
New +$933K 0.01% 1617
2018
Q4
Sell
-3,753
Closed -$346K 2754
2018
Q3
$346K Buy
3,753
+53
+1% +$5.05K ﹤0.01% 1804
2018
Q2
$364K Buy
+3,700
New +$414K ﹤0.01% 1761
2017
Q4
Sell
-9,100
Closed -$857K 2927
2017
Q3
$857K Buy
+9,100
New +$718K 0.01% 1359
2017
Q2
Sell
-2,900
Closed -$232K 2713
2017
Q1
$232K Sell
2,900
-200
-6% -$15.9K ﹤0.01% 1960
2016
Q4
$244K Buy
+3,100
New +$241K ﹤0.01% 1838
2016
Q3
Sell
-3,494
Closed -$240K 2546
2016
Q2
$240K Buy
3,494
+502
+17% +$34.6K ﹤0.01% 1740
2016
Q1
$214K Buy
+2,992
New +$188K ﹤0.01% 1820
2015
Q3
Sell
-2,032
Closed -$109K 3319
2015
Q2
$109K Buy
+2,032
New +$98.8K ﹤0.01% 2183

Other funds holding CMD

Jefferies Group's CMD Position: Q2 2020 in Review

Jefferies Group sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 15,476 shares — an estimated $556K sold.

Jefferies Group first reported a position in CMD in Q2 2015 and held it in 10 quarters. The position peaked at $857K in Q3 2017. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Jefferies Group reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 15,476 Cantel Medical Corporation shares in Q2 2020, an estimated $556K.
  • Jefferies Group first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 10 quarters.
  • Jefferies Group's Cantel Medical Corporation position peaked at $857K in Q3 2017.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.